[1]刘 栋,张 宁,仝 慧,等.外源性生物素对基于生物素 - 链霉亲和素化学发光技术干扰的研究进展[J].现代检验医学杂志,2021,36(03):161-164.[doi:10.3969/j.issn.1671-7414.2021.03.038]
 LIU Dong,TONG Hui,CHEN Bin,et al.Research Progress of Exogenous Biotin Interference on ChemiluminescenceImmunoassay Based on Biotin-avidin System[J].Journal of Modern Laboratory Medicine,2021,36(03):161-164.[doi:10.3969/j.issn.1671-7414.2021.03.038]
点击复制

外源性生物素对基于生物素 - 链霉亲和素化学发光技术干扰的研究进展()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年03期
页码:
161-164
栏目:
综 述
出版日期:
2021-05-31

文章信息/Info

Title:
Research Progress of Exogenous Biotin Interference on ChemiluminescenceImmunoassay Based on Biotin-avidin System
文章编号:
1671-7414(2021)03-161-04
作者:
刘 栋张 宁仝 慧
(1. 铜川市人民医院检验科 , 陕西铜川 727000;2. 西安交通大学第一附属医院检验科 , 西安 710061)
Author(s):
LIU Dong1TONG Hui1CHEN Bin1ZHANG Ning2HU Jian2WANG Xiao-qin2
(1.Department of Clinical Laboratory, the People’s Hospital of Tongchuan City, Shaanxi Tongchuan 727000, China; 2.Departmentof Clinical Laboratory, the First Affiliated Hospital of Medical College of Xi’an Jiaotong University,Xi’an 710061, China)
关键词:
生物素生物素 - 亲和素系统化学发光免疫分析技术干扰
分类号:
R446
DOI:
10.3969/j.issn.1671-7414.2021.03.038
文献标志码:
A
摘要:
基于生物素 - 链霉亲和素系统的化学发光技术被广泛应用,但外源性生物素会对其产生干扰,这种干扰与多种因素相关,如反应模式、检测平台、检测项目和反应体系中的相关要素等。这些因素任何一种发生改变都将对干扰产生不同程度的影响。及时准确的识别干扰有助于减少临床误诊和漏诊。该文对国内外所报道的影响干扰的因素进行综述,为临床实验室人员提供借鉴。

参考文献/References:

[1] 李金明 , 刘辉 . 临床免疫学检验技术 [M]. 北京 : 人民卫生出版社 ,2015. LI Jinming, LIU Hui. Clinical immunology test technology[M]. Beijing: People’s Medical PublishingHouse,2015.
[2] MROSEWSKI I, URBANK M, STAUCH T, et al. Interference from High-Dose biotin intake in immunoassays for potentially time-critical analytes by Roche[J].Archives of Pathology & Laboratory Medicine, 2020,144(9): 1108-1117.
[3] HASLAM S, OAKEY J, BROWN A, et al. A comparison of biotin interference in routine immunoassays onthe Roche Cobas 8000, Beckman Coulter DXi and Siemens Advia Centaur XPT immunoassay platforms[J].Clinical Chemistry and Laboratory Medicine, 2019,57(11): e287-e290.
[4] U S Food and Drug Administration. The FDA warnsthat biotin may interfere with lab tests: FDA safetycommunication[OL]. https://www.fda.gov/Medical Devices/ safety/alertsand notices/ucm586505.htm.
[5] Association for Clinical Biochemistry & LaboratoryMedicine. A statement from the ACB scientific committee regarding biotin / vitamin B7 interference in immunoassays issued July 2018[OL]. http://www.acb.org.uk/docs/default-source/ documents/statement-from-acbscicom-biotin-oct 2018-1.
[6] Bundesinstitut fur Arzneimittel und Medizinprodukte[Federal Institute for Drugs and Medical Devices].Rote-Hand-Brief zu biotinhaltigen Arzneimitteln:Risiko falscher Ergebnisse von Laboruntersuchungendurch Biotininterferenzen[OL]. https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/ RHB/2019/rhb-biotin.html.
[7] European Medicines Agency. PRAC recommendations on signals[OL]. https://www.ema.europa.eu/en/documents/prac-recommendation/pracrecommendations-signals-adopted-14-17-january-2019-prac-meeting_en.pdf.
[8] KWOK J S, CHAN I H, CHAN M H. Biotin interference on TSH and free thyroid hormone measurement[J]. Pathology, 2012, 44(3): 278-280.
[9] 中华人民共和国国家卫生健康委员会 .WS/T 578.5-2018.中国居民膳食营养素参考摄入量 第 5 部分:水溶性维生素(发布稿)[S]. 北京:中国标准出版社,2018. National Health Commission of the People’s Republicof China. WS/T 578.5-2018 Chinese dietary referenceintakes Part 5: Water-soluble vitamin[S].Beijing: Standards Press of China, 2018.
[10] MOCK D M. Biotin: from nutrition to therapeutics[J].The Journal of Nutrition, 2017, 147(8): 1487-1492.
[11] TOURBAH A, LEBRUN-FRENAY C, EDAN G, et al.MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind,placebo-controlled study[J]. Multiple Sclerosis (Houndmills, Basingstoke, England), 2016, 22(13): 1719-1731.
[12] BAILEY R L, GAHCHE J J, LENTINO C V, et al.Dietary supplement use in the United States, 2003-2006[J]. The Journal of Nutrition, 2011, 141(2): 261-266.
[13] LI Jieli, WAGAR EA, MENG Q H. Comprehensiveassessment of biotin interference in immunoassays[J].Clinica Chimica Acta, 2018, 487: 293-298.
[14] 刘栋.生物素对基于生物素 - 链霉亲和素化学发光技术干扰的影响因素和特征研究 [D].西安:西安交通大学,2020. LIU Dong. Study of the interference and characteristicsof biotin on chemiluminescence immunoassay basedon the biotin-avidin system[D]. Xi’an :Xi’an JiaotongUniversity,2020.
[15] 冯珍如 . 生物素对生物素 - 链霉亲合素免疫分析系统干扰的研究进展 [J]. 临床检验杂志 ,2019,37(1):1-4. FENG Zhenru. Research progress on interference of biotin on biotin-streptavidin immune analysis system[J].Chinese Journal of Clinical Laboratory Science,2019,37(1):1-4.
[16] PIKETTY M L, POLAK M, FLECHTNER I, et al.False biochemical diagnosis of hyperthyroidism instreptavidin-biotin-based immunoassays: the problemof biotin intake and related interferences[J]. ClinicalChemistry and Laboratory Medicine, 2017, 55(6): 780-788.
[17] OSTROWSKA M, BARTOSZEWICZ Z, BEDNARCZUK T, et al. The effect of biotin interference on the results of blood hormone assays[J]. EndokrynologiaPolska, 2019, 70(1): 102-121.
[18] WILLEMAN T, CASEZ O, FAURE P, et al. Evaluationof biotin interference on immunoassays: new data fortroponin I, digoxin, NT-Pro-BNP, and progesterone[J].Clinical Chemistry and Laboratory Medicine, 2017,55(10): E226-E229.
[19] TRAMBAS C, LU Zhong, YEN T, et al. Characterization of the scope and magnitude of biotin interferencein susceptible Roche Elecsys competitive and sandwichimmunoassays[J]. Annals of Clinical Biochemistry,2018, 55(2): 205-215.
[20] ALI M, RAJAPAKSHE D , CAO Liyun, et al. Discordant analytical results caused by biotin interference ondiagnostic immunoassays in a pediatric hospital[J]. Annals of Clinical and Laboratory Science, 2017, 47(5):638-640.
[21] LUONG J H, MALE K B, GLENNON J D. Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat[J]. BiotechnologyAdvances, 2019, 37(5): 634-641.
[22] 格尔格 M,希尔林豪斯 L, 希尔策尔 K, 等 . 新的生物素特异性单克隆抗体及其用途:瑞士,CN201780080672.X [P].
[2017-12-22],
[2020-06-10]. http://epub.cnipa.gov.cn/patentoutline.action. GELGER M, HILLINGHOUSE L,HUOYE K, etal. New biotin-specific monoclonal antibody and itsapplication :Switzerland ,CN201780080672.X [P].
[2017-12-22].
[2020-06-10]. http://epub.cnipa.gov.cn/patentoutline.action.

相似文献/References:

[1]郝玉萍,薛金莲,樊阳阳,等.孕妇血清生物素水平与胎儿生长及早产的相关性分析[J].现代检验医学杂志,2021,36(02):148.[doi:doi:10.3969/j.issn.1671-7414.2021.02.035]
 HAO Yu-ping,XUE Jin-lian,FAN Yang-yang,et al.Analysis of Correlation between Serum Biotin Level and Fetal Growth and Premature Delivery in Pregnant Women[J].Journal of Modern Laboratory Medicine,2021,36(03):148.[doi:doi:10.3969/j.issn.1671-7414.2021.02.035]
[2]陈 龙,郑详武.建立一种基于BAS化学发光技术检测血清β-hCG,Prog水平的抗生物素干扰方法[J].现代检验医学杂志,2024,39(01):141.[doi:10.3969/j.issn.1671-7414.2024.01.026]
 CHEN Long,ZHENG Xiangwu.Establish an Anti-biotin Interference Method to Detect Serum β-hCG and Prog Levels Based on BAS Immunoassays[J].Journal of Modern Laboratory Medicine,2024,39(03):141.[doi:10.3969/j.issn.1671-7414.2024.01.026]

备注/Memo

备注/Memo:
作者简介:刘栋(1981-),男,硕士,副主任检验技师。主要研究方向:临床生化检验和实验室质量控制,E-mail:duguke@126.com。
通讯作者:王晓琴,女,主任检验技师,硕士研究生导师 ,E-mail:15353731002@163.com。
更新日期/Last Update: 1900-01-01